Functionally, Miz-1 expression correlates with favorable outcomes in neuroblastoma [6], [29], while excess Myc functions as a potent oncoprotein [30], suggesting a possible antagonistic relationship between Miz-1 and Myc in cancer. Here, ZBTB17 is linked to neuroblastoma.